Tevogen Bio Warrant (TVGNW)

• Market cap: $9.23M
• 1 day: 1.21%
• 5 days: 8.89%
• 1 month: -8.73%
• 3 months: -17.02%
• 6 months: 0.6%
• Year to date: -16.33%
• 1 year: -49.29%
• 5 years: -88.84%
• 10 years: -88.84%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17